OpenAlex
Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
Work
Year: 2022
Type: article
Abstract: In this article, 34 anticoagulant drugs were screened in silico against the main protease (Mpro) of SARS-CoV-2 using molecular docking tools. Idraparinux, fondaparinux, eptifibatide, heparin, and tica... more
Cites: 87
Cited by: 42
Related to: 10
FWCI: 7.591
Citation percentile (by year/subfield): 99.99
Open Access status: gold
APC paid (est): $2,490